Status:
UNKNOWN
Quality of Life Among Testicular Cancer Survivors
Lead Sponsor:
Rabin Medical Center
Conditions:
Testicular Neoplasms
Spermatic Cord Torsion
Eligibility:
MALE
18-75 years
Brief Summary
Testicular Cancer is the most prevalent malignancy among men between 20 and 34 years of age, with incidence rates rising in western countries including Israel. Cure rate of testicular cancer exceeds 9...
Detailed Description
The study will be conducted in RMC, Beilinson and Golda. Eligible male patient list will be drawn from the Rabin Medical Center (RMC) operation rooms' data system. Patients will be contacted by their...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Group1: Testicular cancer long-term survivors
- Male subjects between 2 to 10 years after testicular cancer diagnosis, who have completed treatment and are regarded as complete responders.
- Able to give informed consent Group 2: Benign testicular conditions patients
- Male subjects between 2 to 10 years after testicular surgery due to a benign condition.
- Able to give informed consent Group 3: Healthy Controls
- Healthy males
- Able to give informed consent Partners of males from above 3 groups
- Females or males
- In a couple relationship with a man of 1 of the above groups, for 1 year or longer.
- Able to give informed consent
- Exclusion criteria:
- Group1: Testicular cancer long-term survivors
- Inability to answer questionnaires (i.e due to mental impairment).
- Another malignancy, other than non-invasive skin basal cell carcinoma (BCC) or squamous cell carcinoma (SCC).
- Testicular cancer recurrence. Group 2: Benign testicular conditions patients
- Inability to answer questionnaires.
- Any history of malignancy other than non-invasive skin BCC or SCC. Group 3: Healthy Controls
- Inability to answer questionnaires.
- Any history of malignancy other than non-invasive skin BCC or SCC.
- Any history of testicular surgery or diagnosed testicular problems in adulthood or childhood.
- Partners of males from above 3 groups
- \- Inability to answer questionnaires.
Exclusion
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2018
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT02304575
Start Date
January 1 2015
End Date
November 1 2018
Last Update
October 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center, Beilinson & Hasharon Hospitals
Petah Tikva, Israel